百济神州 (688235.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

453.2x

EV/EBITDA

112.6x

Market Cap

CNY 426.70B

MomentumView details →

1D Return

−4.35%

YTD Return

—

RSI (14)

46.8

ValuationView details →

P/E (Fwd)

453.2x

EV/EBITDA

112.6x

Market Cap

CNY 426.70B

RSI (14)

46.8

MomentumView details →

1D Return

−4.35%

YTD Return

—

ProfitabilityView details →

Gross Margin

88.32%

Net Margin

7.77%

EBITDA Margin

8.89%

ROE (TTM)

9.58%

ROA (TTM)

5.35%

Asset Turnover

0.70x

GrowthView details →

Revenue YoY

+36.18%

EPS YoY

—

FCF YoY

+953.69%

Revenue CAGR 3Y

+58.68%

EPS CAGR 3Y

+128.30%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 1.06

EPS Surprise

22.97%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.14

Avg Surprise (4Q)

22.97%

Rev Surprise

4.15%

Capital & dividendView details →

Debt/Equity

0.22x

Current Ratio

3.73x

Quick Ratio

3.34x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

40.72B

Net Income (TTM)

3.16B

Op. CF (TTM)

15.26B

Next earningsNov 5, 2026 →

Latest newsMore news →

President Donald J. Trump announced agreements with nine additional pharmaceutical manufacturers to lower drug prices for Americans in line with most-favored-nation pricing.4d ago

BeOne Medicines announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients and strengthen its U.S. manufacturing footprint.4d ago

Similar companies

Green Cross Holdings Corporation005250.KS NeoImmuneTech, Inc.950220.KQ AbClon Inc.174900.KQ Prestige BioPharma Limited950210.KS GI Innovation, Inc.358570.KQ Medy-Tox Inc.086900.KQ Find similar companies →

Latest newsMore news →

President Donald J. Trump announced agreements with nine additional pharmaceutical manufacturers to lower drug prices for Americans in line with most-favored-nation pricing.4d ago BeOne Medicines announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients and strengthen its U.S. manufacturing footprint.4d ago